tiprankstipranks
Trending News
More News >
Immunome (IMNM)
NASDAQ:IMNM
US Market
Advertisement

Immunome (IMNM) Technical Analysis

Compare
346 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
6Neutral
8Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Immunome’s (IMNM) Moving Averages Convergence Divergence (MACD) indicator is 0.72, suggesting Immunome is a Buy.
Immunome’s (IMNM) 20-Day exponential moving average is 15.32, while Immunome’s (IMNM) share price is $15.24, making it a Sell.
Immunome’s (IMNM) 50-Day exponential moving average is 13.62, while Immunome’s (IMNM) share price is $15.24, making it a Buy.

Immunome (IMNM) Pivot Points

Nov 09, 2025, 12:21 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
14.65
14.95
15.23
15.53
15.81
16.11
16.39
Fibonacci
14.95
15.17
15.31
15.53
15.75
15.89
16.11
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Immunome (IMNM) Moving Averages

Nov 09, 2025, 12:21 PM
Period
Simple
Exponential
MA5
15.70Sell
15.55Sell
MA10
15.93Sell
15.69Sell
MA20
15.84Sell
15.32Sell
MA50
12.83Buy
13.62Buy
MA100
11.30Buy
12.11Buy
MA200
9.99Buy
11.03Buy
Immunome’s (IMNM) 10-Day exponential moving average is 15.69, while Immunome’s (IMNM) share price is $15.24, making it a Sell.
Immunome’s (IMNM) 100-Day exponential moving average is 12.11, while Immunome’s (IMNM) share price is $15.24, making it a Buy.
Immunome’s (IMNM) stock price is $15.24 and Immunome’s (IMNM) 50-day simple moving average is 12.83, creating a Buy signal.
Immunome’s (IMNM) stock price is $15.24 and Immunome’s (IMNM) 100-day simple moving average is 11.30, creating a Buy signal.
Immunome’s (IMNM) stock price is $15.24 and Immunome’s (IMNM) 200-day simple moving average is 9.99, creating a Buy signal.

Immunome (IMNM) Technical Indicators

Nov 09, 2025, 12:21 PM
Name
Value
Implied Action
RSI (14)
52.60
Neutral
STOCH (9,6)
21.29
Neutral
STOCHRSI (14)
21.29
Neutral
MACD (12,26)
0.72
Buy
ADX (14)
43.18
Neutral
Williams %R
-81.42
Buy
CCI (14)
-75.16
Neutral
ATR (14)
1.13
-
Ultimate Oscillator
47.09
Neutral
ROC
-6.22
Sell
Immunome’s (IMNM) Relative Strength Index (RSI) is 52.60, creating a Neutral signal.
Immunome’s (IMNM) Trend Strength Indicator (ADX) is 43.18, creating a Neutral signal.
Immunome’s (IMNM) Commodity Channel Index (CCI) is -75.16, creating a Neutral signal.
Immunome’s (IMNM) Price Rate of Change (ROC) is -6.22, creating a Sell signal.

FAQ

Is IMNM a Buy, Hold, or Sell?
Based on IMNM’s technical indicators, IMNM is a Hold.
    What is IMNM’s RSI (14)?
    IMNM’s RSI (14) is 52.60, which suggests IMNM is a Neutral.
      What is IMNM’s MACD?
      IMNM’s MACD is 0.72, which suggests IMNM is a Buy.
        What is IMNM’s 5-day moving average?
        IMNM’s 5-day moving average is 15.70, which suggests IMNM is a Sell.
          What is IMNM’s 20-day moving average?
          IMNM 20-day moving average is 15.84, which suggests IMNM is a Sell.
            What is IMNM’s 50-day moving average?
            IMNM’s 50-day moving average is 12.83, which suggests IMNM is a Buy.
              What is IMNM’s 200-day moving average?
              IMNM’s 200-day moving average is 9.99, which suggests IMNM is a Buy.
                What is IMNM’s Williams % R (14)?
                IMNM’s Williams % R (14) is -81.42, which suggests IMNM is a Buy.
                  What is IMNM’s CCI (14)?
                  IMNM’s CCI (14) is -75.16, which suggests IMNM is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis